Panthera Biopartners, a UK Site Management Organization (SMO) which runs commercial clinical trials for the pharmaceutical industry, has appointed Mark Egerton as Chairman. Mark brings extensive experience in the pharmaceutical industry across the UK and the U.S. He is currently Chairman of Newmarket Strategy and was previously CEO of Quotient Sciences, where he oversaw significant growth and international expansion. Commenting on his appointment, Mark said, “I am delighted to join the boa...